MSI Financial Services’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

MSI Financial Services’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12K	Buy	+125	New	+$13.2K	﹤0.01%	2728

Other funds holding SIOX

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSI Financial Services's SIOX Position: Q4 2016 in Review

MSI Financial Services opened a new position in Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2016: 125 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #2728 among its holdings.

101 funds tracked by Wall St. Rank hold SIOX as of Q4 2016.

MSI Financial Services held 125 shares of Sio Gene Therapies Inc. Common Stock worth $12K as of Q4 2016.
Sio Gene Therapies Inc. Common Stock was a new MSI Financial Services position in Q4 2016.
Sio Gene Therapies Inc. Common Stock made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2728 holding.
101 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.